- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cost-effectiveness analysis of introducing HTLV-1 testing in South Africa ; volume:12 ; number:1 ; day:28 ; month:8 ; year:2015 ; pages:1 ; date:12.2015
Retrovirology ; 12, Heft 1 (28.8.2015), 1, 12.2015
- Urheber
-
Sykes, Wendy
Coleman, Charl
Beck, Genevieve
Mhlanga, Jabu
Hlela, Carol
Custer, Brian
Murphy, Edward L.
Vermeulen, Marion
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-12-S1-P81
- URN
-
urn:nbn:de:101:1-2020100521055051086591
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sykes, Wendy
- Coleman, Charl
- Beck, Genevieve
- Mhlanga, Jabu
- Hlela, Carol
- Custer, Brian
- Murphy, Edward L.
- Vermeulen, Marion
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cost-effectiveness of introducing a rotavirus vaccine in developing countries: The case of Mexico
Cost-effectiveness analysis of molecular testing for cytologically indeterminate thyroid nodules
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Pulmonary function testing in HTLV-I and HTLV-II infected humans: a cohort study
The probability of cost-effectiveness
Cost-effectiveness analysis for clinicians
COVID-19 testing protocols to guide duration of isolation: a cost-effectiveness analysis
Costs and cost-effectiveness of HIV counselling and testing modalities in Southern Mozambique
Impact and cost-effectiveness of chlamydia testing in Scotland: a mathematical modelling study
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve
Cost-effectiveness of introducing cone-beam computed tomography (CBCT) in the management of complex phalangeal fractures: economic simulation
Cost-effectiveness of introducing a rotavirus vaccine in developing countries: The case of Mexico
Cost-effectiveness analysis of molecular testing for cytologically indeterminate thyroid nodules
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Pulmonary function testing in HTLV-I and HTLV-II infected humans: a cohort study
The probability of cost-effectiveness
Cost-effectiveness analysis for clinicians
COVID-19 testing protocols to guide duration of isolation: a cost-effectiveness analysis
Costs and cost-effectiveness of HIV counselling and testing modalities in Southern Mozambique
Impact and cost-effectiveness of chlamydia testing in Scotland: a mathematical modelling study
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve
Cost-effectiveness of introducing cone-beam computed tomography (CBCT) in the management of complex phalangeal fractures: economic simulation
Cost-effectiveness of introducing a rotavirus vaccine in developing countries: The case of Mexico
Cost-effectiveness analysis of molecular testing for cytologically indeterminate thyroid nodules
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Pulmonary function testing in HTLV-I and HTLV-II infected humans: a cohort study
The probability of cost-effectiveness
Cost-effectiveness analysis for clinicians
COVID-19 testing protocols to guide duration of isolation: a cost-effectiveness analysis
Costs and cost-effectiveness of HIV counselling and testing modalities in Southern Mozambique
Impact and cost-effectiveness of chlamydia testing in Scotland: a mathematical modelling study
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve